Literature DB >> 18362022

Recurrent intrauterine fetal loss due to near absence of HERG: clinical and functional characterization of a homozygous nonsense HERG Q1070X mutation.

Zahurul A Bhuiyan1, Tarek S Momenah, Qiuming Gong, Ahmad S Amin, Saleh Al Ghamdi, Julene S Carvalho, Tessa Homfray, Marcel M A M Mannens, Zhengfeng Zhou, Arthur A M Wilde.   

Abstract

BACKGROUND: Inherited arrhythmias may underlie intrauterine and neonatal arrhythmias. Resolving the molecular genetic nature of these rare cases provides significant insight into the role of the affected proteins in arrhythmogenesis and (extra-) cardiac development.
OBJECTIVE: The purpose of this study was to perform clinical, molecular, and functional studies of a consanguineous Arabian family with repeated early miscarriages and two intrauterine fetal losses in the early part of the third trimester of pregnancy due to persistent arrhythmias.
METHODS: In-depth clinical investigation was performed in two siblings, both of whom developed severe arrhythmia during the second trimester of pregnancy. Homozygosity mapping with microsatellite repeat polymorphic markers encompassing various cardiac ion channel genes linked to electrical instability of the heart was performed. Screening of the candidate gene in the homozygous locus was performed. Biochemical and electrophysiologic analysis was performed to elucidate the function of the mutated gene.
RESULTS: Screening of the HERG gene in the homozygous locus detected a homozygous nonsense mutation Q1070X in the HERG C-terminus in affected children. Biochemical and functional analysis of the Q1070X mutant showed that although the mutant HERG had the ability to traffic to the plasma membrane and to form functional channels, it was destroyed by the nonsense-mediated decay (NMD) pathway before its translation. NMD leads to near absence of HERG in homozygous Q1070X mutation carriers, causing debilitating arrhythmias (prior to birth) in homozygous carriers but no apparent phenotype in heterozygous carriers.
CONCLUSION: Homozygous HERG Q1070X is equivalent to near functional knockout of HERG. Clinical consequences appear early, originating during the early stages of embryonic life. The NMD pathway renders HERG Q1070X functionless before it can form a functional ion channel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362022      PMCID: PMC2682734          DOI: 10.1016/j.hrthm.2008.01.020

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  28 in total

1.  Deletion of protein kinase A phosphorylation sites in the HERG potassium channel inhibits activation shift by protein kinase A.

Authors:  D Thomas; W Zhang; C A Karle; S Kathöfer; W Schöls; W Kübler; J Kiehn
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

Review 2.  A plethora of mechanisms in the HERG-related long QT syndrome. Genetics meets electrophysiology.

Authors:  D M Roden; J R Balser
Journal:  Cardiovasc Res       Date:  1999-11       Impact factor: 10.787

Review 3.  Genetics of cardiac arrhythmias.

Authors:  Arthur A M Wilde; Connie R Bezzina
Journal:  Heart       Date:  2005-10       Impact factor: 5.994

4.  Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.

Authors:  Corey L Anderson; Brian P Delisle; Blake D Anson; Jennifer A Kilby; Melissa L Will; David J Tester; Qiuming Gong; Zhengfeng Zhou; Michael J Ackerman; Craig T January
Journal:  Circulation       Date:  2006-01-24       Impact factor: 29.690

Review 5.  A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance.

Authors:  E Nagy; L E Maquat
Journal:  Trends Biochem Sci       Date:  1998-06       Impact factor: 13.807

6.  Genomic organization and mutational analysis of HERG, a gene responsible for familial long QT syndrome.

Authors:  T Itoh; T Tanaka; R Nagai; T Kamiya; T Sawayama; T Nakayama; H Tomoike; H Sakurada; Y Yazaki; Y Nakamura
Journal:  Hum Genet       Date:  1998-04       Impact factor: 4.132

7.  Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia.

Authors:  M C Sanguinetti; M E Curran; P S Spector; M T Keating
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

8.  A novel approach to identify Duchenne muscular dystrophy patients for aminoglycoside antibiotics therapy.

Authors:  Shigemi Kimura; Kaori Ito; Toshihiko Miyagi; Takashi Hiranuma; Kowasi Yoshioka; Shirou Ozasa; Makoto Matsukura; Makoto Ikezawa; Masafumi Matsuo; Yasuhiro Takeshima; Teruhisa Miike
Journal:  Brain Dev       Date:  2004-12-08       Impact factor: 1.961

9.  Aminoglycoside-mediated rescue of a disease-causing nonsense mutation in the V2 vasopressin receptor gene in vitro and in vivo.

Authors:  Katrin Sangkuhl; Angela Schulz; Holger Römpler; June Yun; Jürgen Wess; Torsten Schöneberg
Journal:  Hum Mol Genet       Date:  2004-03-03       Impact factor: 6.150

10.  Cardiac IKr channels minimally comprise hERG 1a and 1b subunits.

Authors:  Eugenia M C Jones; Elon C Roti Roti; Jinling Wang; Samantha A Delfosse; Gail A Robertson
Journal:  J Biol Chem       Date:  2004-08-10       Impact factor: 5.157

View more
  20 in total

1.  Multiple splicing defects caused by hERG splice site mutation 2592+1G>A associated with long QT syndrome.

Authors:  Matthew R Stump; Qiuming Gong; Zhengfeng Zhou
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-05       Impact factor: 4.733

2.  Inhibition of nonsense-mediated mRNA decay by antisense morpholino oligonucleotides restores functional expression of hERG nonsense and frameshift mutations in long-QT syndrome.

Authors:  Qiuming Gong; Matthew R Stump; Zhengfeng Zhou
Journal:  J Mol Cell Cardiol       Date:  2010-10-28       Impact factor: 5.000

3.  Antenatal presentation of congenital long QT syndrome: A prenatal diagnosis not to be missed.

Authors:  Alban-Elouen Baruteau; Jean-Marc Schleich
Journal:  Pediatr Cardiol       Date:  2008-07-26       Impact factor: 1.655

4.  Association study of the three functional polymorphisms (TAS2R46G>A, OR4C16G>A, and OR4X1A>T) with recurrent pregnancy loss.

Authors:  Chang Soo Ryu; Jung Hyun Sakong; Eun Hee Ahn; Jung Oh Kim; Daeun Ko; Ji Hyang Kim; Woo Sik Lee; Nam Keun Kim
Journal:  Genes Genomics       Date:  2018-09-10       Impact factor: 1.839

5.  Congenital long QT syndrome with compound mutations in the KCNH2 gene.

Authors:  Sachiko Bando; Takeshi Soeki; Tomomi Matsuura; Toshiyuki Niki; Takayuki Ise; Koji Yamaguchi; Yoshio Taketani; Takashi Iwase; Hirotsugu Yamada; Tetsuzo Wakatsuki; Masashi Akaike; Takeshi Aiba; Wataru Shimizu; Masataka Sata
Journal:  Heart Vessels       Date:  2013-09-22       Impact factor: 2.037

6.  A common single nucleotide polymorphism can exacerbate long-QT type 2 syndrome leading to sudden infant death.

Authors:  Eyal Nof; Jonathan M Cordeiro; Guillermo J Pérez; Fabiana S Scornik; Kirstine Calloe; Barry Love; Elena Burashnikov; Gabriel Caceres; Moshe Gunsburg; Charles Antzelevitch
Journal:  Circ Cardiovasc Genet       Date:  2010-02-24

7.  Nonsense-mediated mRNA decay caused by a frameshift mutation in a large kindred of type 2 long QT syndrome.

Authors:  Ignatius Gerardo Zarraga; Li Zhang; Matthew R Stump; Qiuming Gong; G Michael Vincent; Zhengfeng Zhou
Journal:  Heart Rhythm       Date:  2011-03-15       Impact factor: 6.343

8.  Inherited long QT syndrome: clinical manifestation, genetic diagnostics, and therapy.

Authors:  Sven Zumhagen; Birgit Stallmeyer; Corinna Friedrich; Lars Eckardt; Guiscard Seebohm; Eric Schulze-Bahr
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-09-21

9.  Clinical and genetic analysis of long QT syndrome in children from six families in Saudi Arabia: are they different?

Authors:  Zahurul A Bhuiyan; Safar Al-Shahrani; Ayman S Al-Khadra; Saleh Al-Ghamdi; Khalaf Al-Khalaf; Marcel M A M Mannens; Arthur A M Wilde; Tarek S Momenah
Journal:  Pediatr Cardiol       Date:  2009-01-30       Impact factor: 1.655

10.  Early LQT2 nonsense mutation generates N-terminally truncated hERG channels with altered gating properties by the reinitiation of translation.

Authors:  Matthew R Stump; Qiuming Gong; Jonathan D Packer; Zhengfeng Zhou
Journal:  J Mol Cell Cardiol       Date:  2012-09-03       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.